These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9045282)

  • 1. [Current aspects of the etiology of Parkinson disease].
    Fuhr P
    Praxis (Bern 1994); 1997 Jan; 86(3):34-6. PubMed ID: 9045282
    [No Abstract]   [Full Text] [Related]  

  • 2. [New clues to the etiology of Parkinson disease: parkinsonism induced by the neurotoxin MPTP].
    Jonsson G; Sundström E
    Lakartidningen; 1986 Jan; 83(4):215-8. PubMed ID: 3485230
    [No Abstract]   [Full Text] [Related]  

  • 3. More about parkinsonism after taking ecstasy.
    Sewell RA; Cozzi NV
    N Engl J Med; 1999 Oct; 341(18):1400; author reply 1401. PubMed ID: 10577096
    [No Abstract]   [Full Text] [Related]  

  • 4. The MPTP model of Parkinson's disease.
    Smeyne RJ; Jackson-Lewis V
    Brain Res Mol Brain Res; 2005 Mar; 134(1):57-66. PubMed ID: 15790530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do environmental toxins cause Parkinson's disease? A critical review.
    Tanner CM; Langston JW
    Neurology; 1990 Oct; 40(10 Suppl 3):suppl 17-30; discussion 30-1. PubMed ID: 2215971
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of iron in Parkinson disease and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
    Yantiri F; Andersen JK
    IUBMB Life; 1999 Aug; 48(2):139-41. PubMed ID: 10794588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease].
    Jiménez Jiménez FJ; Ladero Quesada JM
    Med Clin (Barc); 1990 Apr; 94(15):585-95. PubMed ID: 2192210
    [No Abstract]   [Full Text] [Related]  

  • 8. [Parkinson's disease--the molecular mechanism].
    Nagatsu T
    Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1341-52. PubMed ID: 1972586
    [No Abstract]   [Full Text] [Related]  

  • 9. Olfactory impairment and Parkinson's disease-like symptoms observed in the common marmoset following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Miwa T; Watanabe A; Mitsumoto Y; Furukawa M; Fukushima N; Moriizumi T
    Acta Otolaryngol Suppl; 2004 Aug; (553):80-4. PubMed ID: 15277042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting programmed cell death in neurodegenerative diseases.
    Vila M; Przedborski S
    Nat Rev Neurosci; 2003 May; 4(5):365-75. PubMed ID: 12728264
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pathogenic substances in Parkinson disease and new therapeutics considering the etiologic mechanism].
    Nagatsu T
    Nihon Rinsho; 1988 Sep; 46(9):2086-97. PubMed ID: 2907356
    [No Abstract]   [Full Text] [Related]  

  • 12. Pattern of dopaminergic loss in the striatum of humans with parkinsonism induced by MPTP.
    Sawle GV
    J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):276. PubMed ID: 10675207
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiology of Parkinson's disease.
    Khandhar SM; Marks WJ
    Dis Mon; 2007 Apr; 53(4):200-5. PubMed ID: 17586326
    [No Abstract]   [Full Text] [Related]  

  • 14. MPTP- but not methamphetamine-induced parkinsonism extends to catecholamine neurons in the gut.
    Natale G; Kastsiuchenka O; Pasquali L; Ruggieri S; Paparelli A; Fornai F
    Ann N Y Acad Sci; 2008 Oct; 1139():345-9. PubMed ID: 18991880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered gene expression profiles reveal similarities and differences between Parkinson disease and model systems.
    Miller RM; Federoff HJ
    Neuroscientist; 2005 Dec; 11(6):539-49. PubMed ID: 16282595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alessandro Agnoli Lecture. Models of basal ganglia dysfunction: predictions and pitfalls.
    Albin RL; Kearney JA
    Funct Neurol; 2000; 15(3):135-46. PubMed ID: 11062842
    [No Abstract]   [Full Text] [Related]  

  • 17. Adenovirus-mediated transduction with human glial cell line-derived neurotrophic factor gene prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopamine depletion in striatum of mouse brain.
    Kojima H; Abiru Y; Sakajiri K; Watabe K; Ohishi N; Takamori M; Hatanaka H; Yagi K
    Biochem Biophys Res Commun; 1997 Sep; 238(2):569-73. PubMed ID: 9299553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetics of Parkinson's disease: a reconsideration.
    Golbe LI
    Neurology; 1990 Oct; 40(10 Suppl 3):suppl 7-14; discussion 14-6. PubMed ID: 2215974
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitochondrial complex-1 in Parkinson's disease.
    Khan SZ
    Neurol India; 2006 Dec; 54(4):351. PubMed ID: 17114838
    [No Abstract]   [Full Text] [Related]  

  • 20. Toxin-induced parkinsonism: recent developments.
    Fruncillo RJ
    Am Fam Physician; 1986 Mar; 33(3):251-4. PubMed ID: 3485368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.